Exercise News and Research

Latest Exercise News and Research

Simple strategies to cope with holiday stress

Dr. Richard Blonna, author, life coach, and stress management expert, offers five simple strategies for managing holiday stress. His approach to managing the worry and anxiety associated with holiday stress is adapted from his new book, Stress Less, Live More; How Acceptance and Commitment Therapy Can Help You Live a Busy Yet Balanced Life.

20 Nov 2010

Psychiatric hospitalization rate decreases among adults with schizophrenia treated with INVEGA SUSTENNA: Study

Schizophrenia is a chronic and disabling brain disorder that affects 1 percent of the U.S. population and results in substantial medical and societal costs, in particular from use of health-care resources. It also can have devastating health-related and social effects on people with the disease, their families and caregivers.

20 Nov 2010

Repeal, replace and revise are the new health overhaul buzzwords as congressional power changes hands

Senate Minority Leader Mitch McConnell and 32 other GOP senators officially filed a brief on Thursday in favor of a court case challenging healthcare reform. McConnell filed a 16-page brief in a federal case based in Florida arguing that a key part of the new healthcare law, the requirement that all individuals have health insurance, was unconstitutional.

20 Nov 2010

Merck wins third FOSAMAX bellwether trial

Merck & Co., Inc. today said a federal court jury in New York found in its favor in the Graves v. Merck case, rejecting the claims of a Florida woman who blamed her dental and jaw related problems on her FOSAMAX use. With today's verdict, Merck has won three of the first four bellwether cases in the FOSAMAX litigation.

20 Nov 2010

Task Force for National Conference on Diabetes issues Call to Action to improve diabetes care

The Task Force for the National Conference on Diabetes issued a Call to Action today entitled Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact. This Call to Action is a result of the National Conference on Diabetes, held earlier this year in Washington, D.C., which was attended by nearly 100 participants representing the Administration, Congress, government officials, public health organizations and industry.

19 Nov 2010

Physical activity may protect high-risk individuals from cognitive decline: Study

Physical activity promotes changes in the brain that may protect high-risk individuals against cognitive decline, including development of Alzheimer's disease, according to a new study done at the University of Wisconsin-Milwaukee (UWM).

19 Nov 2010

KHN column – The Medicare doc fix: Physicians again are staring into the abyss

What used to be an annual exercise -- waiting to see whether and by how much Congress would increase payments to physicians under Medicare -- has now become a more frequent and even more frustrating activity for physicians.

19 Nov 2010

Weight loss surgery ‘sky rockets’ in Australia

According to a new survey nearly ten times more people are resorting to weight loss surgeries in Australia over the past 10 years. In Australia one in five adults are now classified as being obese and this trend shows that public health messages about diet and exercise are not working.

18 Nov 2010

Call for more transparency and improvements to drug safety in Canada

A commissioned discussion paper released today by the Health Council of Canada, Keeping an Eye on Prescription Drugs, Keeping Canadians Safe, underscores the many limitations to how drug safety and effectiveness is monitored and reported in Canada. The report provides clear recommendations for changes to the current system to ensure Canadians are safe from undue pharmaceutical harm.

18 Nov 2010

Technogym launches first U.S. wellness center

Technogym, a world leader in fitness and wellness, launches their first U.S. wellness center in the U.S. in Soho, New York, which will be a one-stop education center, retail location and showroom.

18 Nov 2010

COPD Biomarkers Qualification Consortium launched

The COPD Foundation announces the launch of an unprecedented collaborative effort to pool information on Chronic Obstructive Pulmonary Disease (COPD): the COPD Biomarkers Qualification Consortium (CBQC). The CBQC brings together government agencies, academic institutions and pharmaceutical companies that will share research data on COPD biomarkers—indicators of disease progression/severity.

18 Nov 2010

Cholesterol-lowering statin therapy benefits patients with calcium buildup in arteries

Rolling back suggestions from previous studies, a Johns Hopkins study of 950 healthy men and women has shown that taking daily doses of a cholesterol-lowering statin medication to protect coronary arteries and ward off heart attack or stroke may not be needed for everyone.

17 Nov 2010

Studies explore lifestyle's influence on wellness and brain health

New research is providing a deeper understanding of how individual actions - such as exercising, sensory stimulation, or drinking - influence brain health and outcomes. This new knowledge could ultimately lead to interventions in age-related cognitive declines, drug abuse, stroke, and brain injury, separate from or in combination with traditional pharmacological approaches. These findings were presented at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

17 Nov 2010

Video game-based technologies allow new insight into memory, perception and motor control

New tools inspired by video games are revealing how the brain senses and responds to its surroundings, finds new human and animal research. Taking advantage of state-of-the art technologies to track and mimic real-life environments, these studies show with new detail how the brain navigates, identifies, and remembers a setting. In additional human research, scientists apply these same technological advances to help people who have experienced strokes regain skills.

17 Nov 2010

TexanPlus HMO provides affordable access to cholesterol-lowering prescription drugs

TexanPlus HMO powered by CCRx, a Medicare Advantage plan offered through the Universal American's family of healthcare companies, will provide broad and affordable access to LIPITOR and CRESTOR, two popular cholesterol-lowering prescription drugs.

17 Nov 2010

Risk reduction of 20 ailments with regular exercise: Review

In a review article researchers have concluded that regular exercise cuts the risk of more than 20 illnesses. Some of these include colon cancer, heart disease, diabetes, osteoporosis and stroke said the study published in the International Journal of Clinical Practice.

16 Nov 2010

Canadian government announces new research initiative on childhood obesity

The Honourable Leona Aglukkaq, Minister of Health, today announced new initiatives for research on physical activity and childhood obesity through the Canadian Institutes of Health Research (CIHR).

16 Nov 2010

BTE Technologies acquires patented recumbent strength-training system, Eccentron

BTE Technologies, a leading global innovator in objective evaluation and rehabilitation equipment for physical therapy, occupational therapy, and sports medicine, announces its acquisition of Eccentron™ - a patented recumbent strength-training system that works the muscles eccentrically for rapid strength gains, explosive muscle power, and unparalleled benefits for joint stability and fall prevention - all with minimal strain on the cardiovascular system.

16 Nov 2010

Celladon presents data on Phase 2 CUPID clinical trial for advanced heart failure at American Heart Association

Targeted Genetics Corporation announced that its partner, Celladon Corporation, today presented 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrating significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.

16 Nov 2010

Celladon’s Phase 2 CUPID trial shows improved clinical outcomes in advanced heart failure patients

Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.

15 Nov 2010

Exercise News and Research

Latest Exercise News and Research

Simple strategies to cope with holiday stress

Psychiatric hospitalization rate decreases among adults with schizophrenia treated with INVEGA SUSTENNA: Study

Repeal, replace and revise are the new health overhaul buzzwords as congressional power changes hands

Merck wins third FOSAMAX bellwether trial

Task Force for National Conference on Diabetes issues Call to Action to improve diabetes care

Physical activity may protect high-risk individuals from cognitive decline: Study

KHN column – The Medicare doc fix: Physicians again are staring into the abyss

Weight loss surgery ‘sky rockets’ in Australia

Call for more transparency and improvements to drug safety in Canada

Technogym launches first U.S. wellness center

COPD Biomarkers Qualification Consortium launched

Cholesterol-lowering statin therapy benefits patients with calcium buildup in arteries

Studies explore lifestyle's influence on wellness and brain health

Video game-based technologies allow new insight into memory, perception and motor control

TexanPlus HMO provides affordable access to cholesterol-lowering prescription drugs

Risk reduction of 20 ailments with regular exercise: Review

Canadian government announces new research initiative on childhood obesity

BTE Technologies acquires patented recumbent strength-training system, Eccentron

Celladon presents data on Phase 2 CUPID clinical trial for advanced heart failure at American Heart Association

Celladon’s Phase 2 CUPID trial shows improved clinical outcomes in advanced heart failure patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exercise News and Research

Latest Exercise News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in